|
C12ORF48 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7196899999905E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.816430E-02 |
| Normal-vs-Stage2 |
9.776200E-02 |
| Normal-vs-Stage3 |
3.602900E-04 |
| Normal-vs-Stage4 |
9.984500E-03 |
| Stage1-vs-Stage2 |
7.501400E-01 |
| Stage1-vs-Stage3 |
1.220290E-03 |
| Stage1-vs-Stage4 |
5.039700E-02 |
| Stage2-vs-Stage3 |
5.276300E-02 |
| Stage2-vs-Stage4 |
1.067800E-01 |
| Stage3-vs-Stage4 |
8.320000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.37630000000145E-05 |
| Normal-vs-AfricanAmerican |
1.447810E-02 |
| Normal-vs-Asian |
7.047800E-02 |
| Caucasian-vs-AfricanAmerican |
5.469400E-01 |
| Caucasian-vs-Asian |
1.147840E-01 |
| AfricanAmerican-vs-Asian |
4.124400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.279980E-03 |
| Normal-vs-Female |
2.1103999999994E-05 |
| Male-vs-Female |
6.182800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.420500E-03 |
| Normal-vs-Extreme_Weight |
1.060370E-01 |
| Normal-vs-Obese |
1.482580E-03 |
| Normal-vs-Extreme_Obese |
8.140600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.058400E-02 |
| Normal_Weight-vs-Obese |
7.007800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.786020E-01 |
| Extreme_Weight-vs-Obese |
2.216300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.191200E-01 |
| Obese-vs-Extreme_Obese |
4.458200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.098900E-03 |
| Normal-vs-Age(41-60Yrs) |
5.6104999999973E-05 |
| Normal-vs-Age(61-80Yrs) |
4.719000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.353620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.798200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.835100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.565500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.910200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.621600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.080000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.718200E-03 |
| Normal-VS-Type2 PRCC |
4.022500E-03 |
| Normal-VS-KIRP CIMP |
5.242800E-03 |
| Normal-VS-Unclassified PRCC |
1.039490E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.187600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.128010E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.498200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.946500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.355600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.494000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.645700E-02 |
| Normal-vs-N1 |
1.580630E-04 |
| Normal-vs-N2 |
2.014400E-01 |
| N0-vs-N1 |
1.264480E-03 |
| N0-vs-N2 |
1.204390E-01 |
| N1-vs-N2 |
4.505000E-01 |
|
|
